HAD

BEHAVIORAL2 trials

Sponsors

University Hospital, Montpellier, Institute of Hematology & Blood Diseases Hospital, China

Conditions

AMLPatients Presenting Essure Device Attributed Symptoms

Unknown Phase

Quality of Life Assessment Before and After Essure Removal

CompletedNCT03401437

University Hospital, MontpellierPatients Presenting Essure Device Attributed Symptoms

Start: 2017-01-10End: 2018-11-16Updated: 2019-01-04

Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

RecruitingNCT06529250

Institute of Hematology & Blood Diseases Hospital, ChinaAML

Start: 2024-08-13End: 2028-09-01Target: 148Updated: 2025-01-16